Theralase Technologies Inc. (TLTFF)

Currency in USD
0.1439
-0.0100(-6.50%)
Closed·
TLTFF Scorecard
Full Analysis
Net income is expected to grow this year
TLTFF is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.14390.1500
52 wk Range
0.08000.2700
Key Statistics
Prev. Close
0.1439
Open
0.1489
Day's Range
0.1439-0.15
52 wk Range
0.08-0.27
Volume
19.86K
Average Volume (3m)
61.18K
1-Year Change
10.69%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
TLTFF Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales decline in the current year

Theralase Technologies Inc. News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell

Theralase Technologies Inc. Company Profile

Theralase Technologies Inc., a clinical stage pharmaceutical company, engages in the research, development, and commercialization of light activated photo dynamic compounds and their associated drug formulations to treat cancers, bacteria, and viruses in Canada, the United States, and internationally. The company operates through Drug Division and Device Division segments. It designs, develops, manufactures, and markets super-pulsed laser technology for the healing of chronic knee pain, as well as for off-label use to heal various nerve, muscle, and joint conditions. In addition, the company develops TLD-1433, which is in Phase II clinical trial for the treatment of Bacillus Calmette Guérin-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma In-Situ. Further, it researches, develops, manufactures, and distributes controller-less cool laser therapy systems comprising TLC-900, TLC-300, and TLC-100 to healthcare practitioners primarily for the healing of pain. The company has a collaboration with the National Microbiology Laboratory, a Public Health Agency of Canada for the research and development of a Canadian-based SARS-CoV-2 vaccine. Theralase Technologies Inc. is based in Toronto, Canada.

Compare TLTFF to Peers and Sector

Metrics to compare
TLTFF
Peers
Sector
Relationship
P/E Ratio
−11.4x−5.5x−0.5x
PEG Ratio
−1.44−0.260.00
Price/Book
46.5x0.0x2.6x
Price / LTM Sales
53.5x14.3x3.2x
Upside (Analyst Target)
-491.4%41.2%
Fair Value Upside
Unlock1.6%6.2%Unlock

Earnings

Latest Release
May 29, 2025
EPS / Forecast
-0.01 / --
Revenue / Forecast
91.19K / --
EPS Revisions
Last 90 days

TLTFF Income Statement

FAQ

What Stock Exchange Does Theralase Technologies Inc. Trade On?

Theralase Technologies Inc. is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Theralase Technologies Inc.?

The stock symbol for Theralase Technologies Inc. is "TLTFF."

What Is the Theralase Technologies Inc. Market Cap?

As of today, Theralase Technologies Inc. market cap is 36.02M.

What Is Theralase Technologies Inc.'s Earnings Per Share (TTM)?

The Theralase Technologies Inc. EPS (TTM) is -0.02.

From a Technical Analysis Perspective, Is TLTFF a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Theralase Technologies Inc. Stock Split?

Theralase Technologies Inc. has split 0 times.

How Many Employees Does Theralase Technologies Inc. Have?

Theralase Technologies Inc. has 20 employees.

What is the current trading status of Theralase Technologies Inc. (TLTFF)?

As of 29 Jul 2025, Theralase Technologies Inc. (TLTFF) is trading at a price of 0.14, with a previous close of 0.14. The stock has fluctuated within a day range of 0.14 to 0.15, while its 52-week range spans from 0.08 to 0.27.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.